Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link?
Open Access
- 1 August 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 14 (8), 1934-1942
- https://doi.org/10.1093/ndt/14.8.1934
Abstract
Background. Haemodialysis patients exhibit an excessive burden of atherothrombotic disease, which is not explained adequately by traditional risk factors. Hyperhomocyst(e)inaemia, a consistent finding in uraemic patients, is now widely recognized as an independent risk factor for vascular disease. The aim of this study was to examine the hypothesis that hyperhomocyst(e)inaemia is associated with cardiovascular complications in dialysed patients. Methods. In a cohort of 63 stable chronic haemodialysis patients, we examined the causal relationship between hyperhomocyst(e)inaemia and vascular endothelial and haemostatic function. All their markers were determined before and after an 8-week course of a 10 mg per day oral folate supplementation, a manoeuvre known to decrease hyperhomocyst(e)inaemia in uraemic patients. Results. History of at least one cardiovascular atherothrombotic event was present in 47.6% of the haemodialysed patients, and radiographic evidence of vascular calcifications in 70%. Hyperhomocyst(e)inaemia was found in all patients, averaging 3.5-fold the upper limit of normal values (PPPPPConclusions. Hyperhomocyst(e)inaemia is associated with increased cardiovascular risk in haemodialysis patients. Folate supplementation was partially effective in lowering hyperhomocyst(e)inaemia, but its usefulness in terms of reduction in cardiovascular morbidity and mortality remains to be determined in prospective trials.Keywords
This publication has 42 references indexed in Scilit:
- High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patientsKidney International, 1996
- Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control studyAtherosclerosis, 1995
- Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis.JCI Insight, 1994
- Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patientsKidney International, 1994
- Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart StudyThe Lancet, 1993
- Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor.JCI Insight, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteineAtherosclerosis, 1991
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptorBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987